
Harvard Bioscience HBIO
$ 5.55
2.78%
Annual report 2025
added 03-13-2026
Harvard Bioscience Long Term Debt Current 2011-2026 | HBIO
Annual Long Term Debt Current Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.52 M | 1.16 M | 1.42 M | 2.14 M | 2.14 M | 2.11 M | 2.42 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.42 M | 1.16 M | 1.84 M |
Long Term Debt Current of other stocks in the Medical instruments industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
1.73 M | $ 28.22 | -2.32 % | $ 1.35 B | ||
|
Baxter International
BAX
|
81 M | $ 17.24 | 3.61 % | $ 8.84 B | ||
|
BioLife Solutions
BLFS
|
1.51 M | $ 19.71 | 3.03 % | $ 908 M | ||
|
Ekso Bionics Holdings
EKSO
|
441 K | $ 8.73 | -3.64 % | $ 21.2 M | ||
|
Alcon
ALC
|
80 M | $ 77.31 | 3.54 % | $ 40.4 B | ||
|
Haemonetics Corporation
HAE
|
8.11 M | $ 59.53 | -0.05 % | $ 3 B | ||
|
The Cooper Companies
COO
|
37.8 M | $ 71.73 | 2.97 % | $ 14.3 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 120.49 | 1.57 % | $ 3.86 B | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
413 K | $ 4.19 | -1.18 % | $ 194 M | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 178.3 | -0.24 % | $ 9.5 B | ||
|
Microbot Medical
MBOT
|
296 K | $ 2.35 | 2.62 % | $ 108 M | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.27 | -4.66 % | $ 22.2 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 69.24 | 2.73 % | $ 4.1 B | ||
|
electroCore
ECOR
|
375 K | $ 6.21 | -7.45 % | $ 52.7 K | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 26.66 | 5.42 % | $ 4.48 B | ||
|
Glaukos Corporation
GKOS
|
1.31 M | $ 118.62 | 3.09 % | $ 5.75 B | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
ICU Medical
ICUI
|
13.8 M | $ 123.92 | 3.41 % | $ 3.05 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 9.47 | 1.18 % | $ 196 M | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 462.28 | 2.06 % | $ 165 B | ||
|
ResMed
RMD
|
21.9 M | $ 230.7 | 2.06 % | $ 33.7 B | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 112.41 | 1.89 % | $ 2.54 B | ||
|
Retractable Technologies
RVP
|
286 K | $ 0.68 | -4.59 % | $ 20.4 M | ||
|
Pulse Biosciences
PLSE
|
1.57 M | $ 19.06 | -4.51 % | $ 1.28 B | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 20.88 | -1.0 % | $ 1.03 B | ||
|
STERIS plc
STE
|
34.2 M | $ 225.03 | 2.65 % | $ 22.2 B | ||
|
Stereotaxis
STXS
|
642 K | $ 1.93 | 4.32 % | $ 176 M | ||
|
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 119.03 | 3.05 % | $ 5.31 B | ||
|
Utah Medical Products
UTMD
|
60 K | $ 64.53 | 1.67 % | $ 209 M | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 265.93 | 2.54 % | $ 19.2 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 11.99 | 4.08 % | $ 2.39 B | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 10.17 | 4.85 % | $ 415 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 157.09 | 1.37 % | $ 45.2 B | ||
|
Nephros
NEPH
|
442 K | $ 2.91 | 4.68 % | $ 30.2 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 3.08 | 0.65 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
5.63 M | $ 119.77 | 3.89 % | $ 6.67 M |